CIK: 1230482 - Address: C/O Xeris Biopharma Holdings, Inc., 1375 West Fulton Street, Suite 1300, Chicago, IL 60607
17 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret118-22-6-95415
S%wins63257588635762

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

1/12/23 16:29
1/10/23
HZNPHorizon Therapeutics Public Ltd CoL2HealthDrugPharmaceutical PreparationsSherman Jeffrey WL2OEVP,ChieS.m-762113.080-7-3237D
1/6/23 17:54
1/6/23
HZNPHorizon Therapeutics Public Ltd CoL2HealthDrugPharmaceutical PreparationsSherman Jeffrey WL2OEVP,ChieS.d-588113.290-5-2243M
12/13/22 16:12
12/12/22
HZNPHorizon Therapeutics Public Ltd CoL2HealthDrugPharmaceutical PreparationsSherman Jeffrey WL2OEVP,ChieS-3,160111.450-28-16154M
4/8/22 16:07
4/6/22
HZNPHorizon Therapeutics Public Ltd CoL2HealthDrugPharmaceutical PreparationsSherman Jeffrey WL2OEVP,ChieS-4,622110.020-42-15236D
9/23/21 17:00
9/21/21
HZNPHorizon Therapeutics Public Ltd CoL2HealthDrugPharmaceutical PreparationsSherman Jeffrey WL2OEVP,ChieS.d-5,090110.000-46-18209M
7/2/21 17:02
7/1/21
HZNPHorizon Therapeutics Public Ltd CoL2HealthDrugPharmaceutical PreparationsSherman Jeffrey WL2OEVP,ChieS-5,70795.000-60-23205M
12/9/20 17:05
12/7/20
HZNPHorizon Therapeutics Public Ltd CoL2HealthDrugPharmaceutical PreparationsSherman Jeffrey WL2OEVP,ChieS.m-7,37571.020-104-34203I
7/7/20 18:49
7/6/20
HZNPHorizon Therapeutics Public Ltd CoL2HealthDrugPharmaceutical PreparationsSherman Jeffrey WL2OEVP,ChieS-52357.500-9-3294I
5/12/20 16:12
5/11/20
HZNPHorizon Therapeutics Public Ltd CoL2HealthDrugPharmaceutical PreparationsSherman Jeffrey WL2OEVP,ChieS.d-1,50745.000-33-10302D
8/2/16 16:44
8/2/16
HZNPHorizon Pharma PlcDEHealthDrugPharmaceutical PreparationsSherman Jeffrey WL2OEVP,ChieS-5820.0033-3-2159D122-49823120-1-528-2-9-16
2/29/16 19:10
2/26/16
HZNPHorizon Pharma PlcDEHealthDrugPharmaceutical PreparationsSherman Jeffrey WL2OEVP,ChieS-8220.0033-4-3150D654-32-9715681-1-6-411-3
12/10/15 16:55
12/10/15
HZNPHorizon Pharma PlcDEHealthDrugPharmaceutical PreparationsSherman Jeffrey WL2OEVP,ChieS-8920.0033-4-4105D18247-38-31155-8-1-74-12-9-13-27
9/21/15 18:59
9/21/15
HZNPHorizon Pharma PlcDEHealthDrugPharmaceutical PreparationsSherman Jeffrey WL2OEVP,ChieS-24631.7833-8-7105D89415840-6-45129-12-19-31-24-44-31
7/17/15 16:36
7/15/15
HZNPHorizon Pharma PlcDEHealthDrugPharmaceutical PreparationsSherman Jeffrey WL2OEVP,ChieS.d-95635.5533-27-19113D9991651621817108533-18-50-51-49
11/20/14 18:18
11/19/14
HZNPHorizon Pharma PlcDEHealthDrugPharmaceutical PreparationsSherman Jeffrey WL2OEVP,ChieS-30112.0523-25-2574D451108-6303-1-23-4484915551
5/21/14 17:46
5/19/14
HZNPHorizon Pharma, Inc.DEHealthDrugPharmaceutical PreparationsSherman Jeffrey WILOEVP,ChieS-12112.9423-9-993D25344418418-3-8-2001022-27-7128
1/3/13 14:36
1/2/13
HZNPHorizon Pharma, Inc.DEHealthDrugPharmaceutical PreparationsSherman Jeffrey WILOEVP,ChieS.d-382.361-16-2355D-42-66-31500507-1104216

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact